Funding announced in Budget 2021 will significantly advance Canadian bioscience research and innovation, accelerating ground-breaking missions in critical public health areas like pandemic surveillance and precision medicine in the clinic, while delivering made-in-Canada solutions to anti-microbial resistance, food security and biomanufacturing.
A Made-in-Canada data solution to support Canada’s Variants of Concern Strategy
Genome Canada, in partnership with the Government of Canada, is pleased to announce the development of a new Canadian SARS-CoV-2 Data Portal that will manage and facilitate data sharing of viral genome sequences among Canadian public health labs, researchers and other groups interested in accessing the data for research and innovation purposes.
$8.6 million in federal funding to support healthier Canadians and a resilient food supply
Genomics is on a mission to develop new knowledge, tools and technologies to improve Canadians’ lives.
Reducing the impact of novel SARS-CoV-2 variants is a critical focus of the global COVID-19 response. Genome Canada, through its leadership of the Canadian COVID Genomics Network (CanCOGeN), is part of an integrated national effort to rapidly identify, understand, and track the distribution of these variants in Canada.
(This statement is an updated version of our original statement of Dec. 22, 2020 when the first new variant was identified in the United Kingdom.)